Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(rivastigmine). Showing records 1 – 18 of 18 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Universiteit Utrecht

1. Beeckman, A.E. Lexico-semantic features in early stage Alzheimer's disease: influence of rivastigmine and comparison with elderly controls.

Degree: 2009, Universiteit Utrecht

 Alzheimer’s disease is a devastating and disabling disease and will affect more and more people. Cholinesterase-inhibitors try to slow down this process, but its efficacy… (more)

Subjects/Keywords: Letteren; dementia; Alzheimer's disease; semantics; rivastigmine; Exelon

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Beeckman, A. E. (2009). Lexico-semantic features in early stage Alzheimer's disease: influence of rivastigmine and comparison with elderly controls. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/36236

Chicago Manual of Style (16th Edition):

Beeckman, A E. “Lexico-semantic features in early stage Alzheimer's disease: influence of rivastigmine and comparison with elderly controls.” 2009. Masters Thesis, Universiteit Utrecht. Accessed July 10, 2020. http://dspace.library.uu.nl:8080/handle/1874/36236.

MLA Handbook (7th Edition):

Beeckman, A E. “Lexico-semantic features in early stage Alzheimer's disease: influence of rivastigmine and comparison with elderly controls.” 2009. Web. 10 Jul 2020.

Vancouver:

Beeckman AE. Lexico-semantic features in early stage Alzheimer's disease: influence of rivastigmine and comparison with elderly controls. [Internet] [Masters thesis]. Universiteit Utrecht; 2009. [cited 2020 Jul 10]. Available from: http://dspace.library.uu.nl:8080/handle/1874/36236.

Council of Science Editors:

Beeckman AE. Lexico-semantic features in early stage Alzheimer's disease: influence of rivastigmine and comparison with elderly controls. [Masters Thesis]. Universiteit Utrecht; 2009. Available from: http://dspace.library.uu.nl:8080/handle/1874/36236


Universiteit Utrecht

2. Bon, M.E. The effect of rivastigmine on connected speech assessed by the Boston Cookie Theft picture description task in patients with early Alzheimer’s disease.

Degree: 2010, Universiteit Utrecht

 Background: Rivastigmine delays cognitive deterioration in patients with mild to moderate Alzheimer’s disease (AD). Treatment with rivastigmine results in beneficial effects on cognitive function, ADL… (more)

Subjects/Keywords: Letteren; Rivastigmine, connected speech, Cookie Theft, Alzheimer’s disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bon, M. E. (2010). The effect of rivastigmine on connected speech assessed by the Boston Cookie Theft picture description task in patients with early Alzheimer’s disease. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/179452

Chicago Manual of Style (16th Edition):

Bon, M E. “The effect of rivastigmine on connected speech assessed by the Boston Cookie Theft picture description task in patients with early Alzheimer’s disease.” 2010. Masters Thesis, Universiteit Utrecht. Accessed July 10, 2020. http://dspace.library.uu.nl:8080/handle/1874/179452.

MLA Handbook (7th Edition):

Bon, M E. “The effect of rivastigmine on connected speech assessed by the Boston Cookie Theft picture description task in patients with early Alzheimer’s disease.” 2010. Web. 10 Jul 2020.

Vancouver:

Bon ME. The effect of rivastigmine on connected speech assessed by the Boston Cookie Theft picture description task in patients with early Alzheimer’s disease. [Internet] [Masters thesis]. Universiteit Utrecht; 2010. [cited 2020 Jul 10]. Available from: http://dspace.library.uu.nl:8080/handle/1874/179452.

Council of Science Editors:

Bon ME. The effect of rivastigmine on connected speech assessed by the Boston Cookie Theft picture description task in patients with early Alzheimer’s disease. [Masters Thesis]. Universiteit Utrecht; 2010. Available from: http://dspace.library.uu.nl:8080/handle/1874/179452


Université Laval

3. McDonald, Jaime. Investigating the effect of rivastigmine on postural control in Parkinson's disease dementia.

Degree: 2018, Université Laval

Objectifs : Comparer l’efficacité et l'aspect sécuritaire de la rivastigmine sous forme orale et transdermique destinée au traitement des symptômes liés aux instabilités posturales de… (more)

Subjects/Keywords: Rivastigmine; Troubles de la posture  – Traitement; Maladie de Parkinson

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McDonald, J. (2018). Investigating the effect of rivastigmine on postural control in Parkinson's disease dementia. (Thesis). Université Laval. Retrieved from http://hdl.handle.net/20.500.11794/30262

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

McDonald, Jaime. “Investigating the effect of rivastigmine on postural control in Parkinson's disease dementia.” 2018. Thesis, Université Laval. Accessed July 10, 2020. http://hdl.handle.net/20.500.11794/30262.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

McDonald, Jaime. “Investigating the effect of rivastigmine on postural control in Parkinson's disease dementia.” 2018. Web. 10 Jul 2020.

Vancouver:

McDonald J. Investigating the effect of rivastigmine on postural control in Parkinson's disease dementia. [Internet] [Thesis]. Université Laval; 2018. [cited 2020 Jul 10]. Available from: http://hdl.handle.net/20.500.11794/30262.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

McDonald J. Investigating the effect of rivastigmine on postural control in Parkinson's disease dementia. [Thesis]. Université Laval; 2018. Available from: http://hdl.handle.net/20.500.11794/30262

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Tampere University

4. Dania, Anna. The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis .

Degree: 2014, Tampere University

 Background: To date, clinical trials have reported inconsistent results on the efficacy of the combination therapy of Memantine plus an acetylcholinesterase inhibitor (AChEI) over a… (more)

Subjects/Keywords: Acetylcholinesterase inhibitor; Alzheimer s disease; donepezil; galantamine; memantine; rivastigmine; meta-analysis.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dania, A. (2014). The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis . (Masters Thesis). Tampere University. Retrieved from https://trepo.tuni.fi/handle/10024/96082

Chicago Manual of Style (16th Edition):

Dania, Anna. “The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis .” 2014. Masters Thesis, Tampere University. Accessed July 10, 2020. https://trepo.tuni.fi/handle/10024/96082.

MLA Handbook (7th Edition):

Dania, Anna. “The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis .” 2014. Web. 10 Jul 2020.

Vancouver:

Dania A. The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis . [Internet] [Masters thesis]. Tampere University; 2014. [cited 2020 Jul 10]. Available from: https://trepo.tuni.fi/handle/10024/96082.

Council of Science Editors:

Dania A. The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis . [Masters Thesis]. Tampere University; 2014. Available from: https://trepo.tuni.fi/handle/10024/96082

5. Pons, Mégane. Vers un traitement de la maladie d'Alzheimer : synthèse de nouveaux ligands multi-cibles : Toward an innovative treatment of Alzheimer's disease : Design of novel multi-target directed ligands.

Degree: Docteur es, Chimie, 2019, Normandie

La maladie d’Alzheimer (MA) est une maladie neurodégénérative complexe caractérisée par une perte progressive de la mémoire et de la cognition. C’est la première cause… (more)

Subjects/Keywords: Maladie d'Alzheimer; Ligand multi-cibles; Acétylcholinestérase; Antioxydant; Récepteur nicotinique alpha7; Huprine; Rivastigmine; Donepezil; Alzheimer's disease; Multi-target ligand; Acetylcholinesterase; Antioxidant; Alpha7 nicotinic receptor; Huprine; Rivastigmine; Donepezil; 615.58

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pons, M. (2019). Vers un traitement de la maladie d'Alzheimer : synthèse de nouveaux ligands multi-cibles : Toward an innovative treatment of Alzheimer's disease : Design of novel multi-target directed ligands. (Doctoral Dissertation). Normandie. Retrieved from http://www.theses.fr/2019NORMR082

Chicago Manual of Style (16th Edition):

Pons, Mégane. “Vers un traitement de la maladie d'Alzheimer : synthèse de nouveaux ligands multi-cibles : Toward an innovative treatment of Alzheimer's disease : Design of novel multi-target directed ligands.” 2019. Doctoral Dissertation, Normandie. Accessed July 10, 2020. http://www.theses.fr/2019NORMR082.

MLA Handbook (7th Edition):

Pons, Mégane. “Vers un traitement de la maladie d'Alzheimer : synthèse de nouveaux ligands multi-cibles : Toward an innovative treatment of Alzheimer's disease : Design of novel multi-target directed ligands.” 2019. Web. 10 Jul 2020.

Vancouver:

Pons M. Vers un traitement de la maladie d'Alzheimer : synthèse de nouveaux ligands multi-cibles : Toward an innovative treatment of Alzheimer's disease : Design of novel multi-target directed ligands. [Internet] [Doctoral dissertation]. Normandie; 2019. [cited 2020 Jul 10]. Available from: http://www.theses.fr/2019NORMR082.

Council of Science Editors:

Pons M. Vers un traitement de la maladie d'Alzheimer : synthèse de nouveaux ligands multi-cibles : Toward an innovative treatment of Alzheimer's disease : Design of novel multi-target directed ligands. [Doctoral Dissertation]. Normandie; 2019. Available from: http://www.theses.fr/2019NORMR082


Universiteit Utrecht

6. Frankfort, S.V. Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients.

Degree: 2007, Universiteit Utrecht

 Evaluation of pharmacotherapy and diagnosis and treatment of dementia are important subjects within geriatric medicine. Geriatric patients are more vulnerable for adverse events and pharmacokinetic… (more)

Subjects/Keywords: Farmacie; rivastigmine; Alzheimer's disease; biomarkers; P-glycoprotein; ABCB1; polypharmacy; medication evaluation; pharmacokinetics; pharmacogenetics; elderly

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Frankfort, S. V. (2007). Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/19078

Chicago Manual of Style (16th Edition):

Frankfort, S V. “Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients.” 2007. Doctoral Dissertation, Universiteit Utrecht. Accessed July 10, 2020. http://dspace.library.uu.nl:8080/handle/1874/19078.

MLA Handbook (7th Edition):

Frankfort, S V. “Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients.” 2007. Web. 10 Jul 2020.

Vancouver:

Frankfort SV. Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2007. [cited 2020 Jul 10]. Available from: http://dspace.library.uu.nl:8080/handle/1874/19078.

Council of Science Editors:

Frankfort SV. Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients. [Doctoral Dissertation]. Universiteit Utrecht; 2007. Available from: http://dspace.library.uu.nl:8080/handle/1874/19078

7. Fernandes, Sílvia Andreia Domingos. Development of an organocatalytic method for the enantioselective synthesis of rivastigmine.

Degree: 2016, Universidade de Évora

 The focus of this thesis was the study of a recently developed class of picolinamide cinchona alkaloid derivatives for the synthesis of Rivastigmine, a biologically… (more)

Subjects/Keywords: Ketimine reduction; Chiral amines; Cinchona alkaloid derivatives; Rivastigmine; Redução de cetiminas; Aminas quirais; Derivados de alcaloides de cinchona; Rivastigmina

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fernandes, S. A. D. (2016). Development of an organocatalytic method for the enantioselective synthesis of rivastigmine. (Thesis). Universidade de Évora. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:dspace.uevora.pt:10174/18609

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fernandes, Sílvia Andreia Domingos. “Development of an organocatalytic method for the enantioselective synthesis of rivastigmine.” 2016. Thesis, Universidade de Évora. Accessed July 10, 2020. https://www.rcaap.pt/detail.jsp?id=oai:dspace.uevora.pt:10174/18609.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fernandes, Sílvia Andreia Domingos. “Development of an organocatalytic method for the enantioselective synthesis of rivastigmine.” 2016. Web. 10 Jul 2020.

Vancouver:

Fernandes SAD. Development of an organocatalytic method for the enantioselective synthesis of rivastigmine. [Internet] [Thesis]. Universidade de Évora; 2016. [cited 2020 Jul 10]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:dspace.uevora.pt:10174/18609.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fernandes SAD. Development of an organocatalytic method for the enantioselective synthesis of rivastigmine. [Thesis]. Universidade de Évora; 2016. Available from: https://www.rcaap.pt/detail.jsp?id=oai:dspace.uevora.pt:10174/18609

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queens University

8. Fong, Raymond. Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario .

Degree: Community Health and Epidemiology, 2011, Queens University

 Background: Dementia leads to progressive cognitive and functional decline. Population aging is a concern, and the healthcare system must refocus its limited resources to keep… (more)

Subjects/Keywords: Alzheimer's; Dementia; Cholinesterase Inhibitors; Donepezil; Galantamine; Rivastigmine; Resource Utilization; Ontario; Cost-Minimization; Comparative Study; Epidemiology; Economics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fong, R. (2011). Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/6857

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fong, Raymond. “Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario .” 2011. Thesis, Queens University. Accessed July 10, 2020. http://hdl.handle.net/1974/6857.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fong, Raymond. “Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario .” 2011. Web. 10 Jul 2020.

Vancouver:

Fong R. Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario . [Internet] [Thesis]. Queens University; 2011. [cited 2020 Jul 10]. Available from: http://hdl.handle.net/1974/6857.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fong R. Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario . [Thesis]. Queens University; 2011. Available from: http://hdl.handle.net/1974/6857

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

9. Κανή, Χαρίκλεια. Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση.

Degree: 2009, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

 To examine whether Cholinesterase Inhibitors (ChEIs) and memantine are superior to placebo in the treatment a) of Alzheimer’s disease (AD) for at least 6 months… (more)

Subjects/Keywords: Δονεπεζίλη; Γκαλανταμίνη; Ριβαστιγμίνη; Μεμαντίνη; Νόσος Alzheimer; Άνοια, Αγγειακή; Συστηματική ανασκόπηση; Μετά - ανάλυση; Donepezil; Galantamine; Rivastigmine; Memantine; Alzheimer's disease; Vascular dementia; Systematic review; Meta - analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Κανή, . . (2009). Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/19819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Κανή, Χαρίκλεια. “Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση.” 2009. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed July 10, 2020. http://hdl.handle.net/10442/hedi/19819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Κανή, Χαρίκλεια. “Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση.” 2009. Web. 10 Jul 2020.

Vancouver:

Κανή . Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2009. [cited 2020 Jul 10]. Available from: http://hdl.handle.net/10442/hedi/19819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Κανή . Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2009. Available from: http://hdl.handle.net/10442/hedi/19819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université de Montréal

10. Vintiloiu, Anda. In situ-forming injectable organogel implant for sustained release of rivastigmine .

Degree: 2007, Université de Montréal

Subjects/Keywords: Organogel; Libération prolongée; Implant autoformant in situ; Rivastigmine; Maladie d'Alzheimer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vintiloiu, A. (2007). In situ-forming injectable organogel implant for sustained release of rivastigmine . (Thesis). Université de Montréal. Retrieved from http://hdl.handle.net/1866/15666

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vintiloiu, Anda. “In situ-forming injectable organogel implant for sustained release of rivastigmine .” 2007. Thesis, Université de Montréal. Accessed July 10, 2020. http://hdl.handle.net/1866/15666.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vintiloiu, Anda. “In situ-forming injectable organogel implant for sustained release of rivastigmine .” 2007. Web. 10 Jul 2020.

Vancouver:

Vintiloiu A. In situ-forming injectable organogel implant for sustained release of rivastigmine . [Internet] [Thesis]. Université de Montréal; 2007. [cited 2020 Jul 10]. Available from: http://hdl.handle.net/1866/15666.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Vintiloiu A. In situ-forming injectable organogel implant for sustained release of rivastigmine . [Thesis]. Université de Montréal; 2007. Available from: http://hdl.handle.net/1866/15666

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université du Québec à Montréal

11. Chouinard, Sylvie. Effet des inhibiteurs d'acétylcholinestérase sur le fonctionnement cognitif dans la schizophrénie.

Degree: 2009, Université du Québec à Montréal

 La schizophrénie est une psychopathologie caractérisée par une perturbation du fonctionnement cognitif. Malgré l'efficacité de certains traitements antipsychotiques en regard de certains symptômes négatifs et… (more)

Subjects/Keywords: Acétylcholinestérase; Inhibiteur enzymatique; Mémoire; Rivastigmine; Schizophrénie; Trouble de la cognition

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chouinard, S. (2009). Effet des inhibiteurs d'acétylcholinestérase sur le fonctionnement cognitif dans la schizophrénie. (Thesis). Université du Québec à Montréal. Retrieved from http://archipel.uqam.ca/2498/1/D1860.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chouinard, Sylvie. “Effet des inhibiteurs d'acétylcholinestérase sur le fonctionnement cognitif dans la schizophrénie.” 2009. Thesis, Université du Québec à Montréal. Accessed July 10, 2020. http://archipel.uqam.ca/2498/1/D1860.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chouinard, Sylvie. “Effet des inhibiteurs d'acétylcholinestérase sur le fonctionnement cognitif dans la schizophrénie.” 2009. Web. 10 Jul 2020.

Vancouver:

Chouinard S. Effet des inhibiteurs d'acétylcholinestérase sur le fonctionnement cognitif dans la schizophrénie. [Internet] [Thesis]. Université du Québec à Montréal; 2009. [cited 2020 Jul 10]. Available from: http://archipel.uqam.ca/2498/1/D1860.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chouinard S. Effet des inhibiteurs d'acétylcholinestérase sur le fonctionnement cognitif dans la schizophrénie. [Thesis]. Université du Québec à Montréal; 2009. Available from: http://archipel.uqam.ca/2498/1/D1860.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

12. Frankfort, S.V. Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients.

Degree: 2007, University Utrecht

 Evaluation of pharmacotherapy and diagnosis and treatment of dementia are important subjects within geriatric medicine. Geriatric patients are more vulnerable for adverse events and pharmacokinetic… (more)

Subjects/Keywords: rivastigmine; Alzheimer's disease; biomarkers; P-glycoprotein; ABCB1; polypharmacy; medication evaluation; pharmacokinetics; pharmacogenetics; elderly

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Frankfort, S. V. (2007). Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/19078 ; URN:NBN:NL:UI:10-1874-19078 ; urn:isbn:978-393-4419-4 ; URN:NBN:NL:UI:10-1874-19078 ; https://dspace.library.uu.nl/handle/1874/19078

Chicago Manual of Style (16th Edition):

Frankfort, S V. “Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients.” 2007. Doctoral Dissertation, University Utrecht. Accessed July 10, 2020. https://dspace.library.uu.nl/handle/1874/19078 ; URN:NBN:NL:UI:10-1874-19078 ; urn:isbn:978-393-4419-4 ; URN:NBN:NL:UI:10-1874-19078 ; https://dspace.library.uu.nl/handle/1874/19078.

MLA Handbook (7th Edition):

Frankfort, S V. “Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients.” 2007. Web. 10 Jul 2020.

Vancouver:

Frankfort SV. Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients. [Internet] [Doctoral dissertation]. University Utrecht; 2007. [cited 2020 Jul 10]. Available from: https://dspace.library.uu.nl/handle/1874/19078 ; URN:NBN:NL:UI:10-1874-19078 ; urn:isbn:978-393-4419-4 ; URN:NBN:NL:UI:10-1874-19078 ; https://dspace.library.uu.nl/handle/1874/19078.

Council of Science Editors:

Frankfort SV. Pharmacotherapy, clinical pharmacology and biomarker research in geriatric patients. [Doctoral Dissertation]. University Utrecht; 2007. Available from: https://dspace.library.uu.nl/handle/1874/19078 ; URN:NBN:NL:UI:10-1874-19078 ; urn:isbn:978-393-4419-4 ; URN:NBN:NL:UI:10-1874-19078 ; https://dspace.library.uu.nl/handle/1874/19078


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

13. Μέλλιος, Γεώργιος. Η επίδραση της ριβαστιγμίνης σε ανώτερες φλοιϊκές λειτουργίες (συμπεριφορά) επιμύων, κατόπιν καταστροφής του βασικού πυρήνα του Meynert.

Degree: 2006, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

Subjects/Keywords: Συμπεριφορά; Μνήμη; Μάθηση; Ριβαστιγμίνη; Βασικός πυρήνας του Meynert; Νόσος Alzheimer; Behavior; Memory; Learning; Rivastigmine; Nucleus basalis of Meynert; Alzheimer's disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Μέλλιος, . . (2006). Η επίδραση της ριβαστιγμίνης σε ανώτερες φλοιϊκές λειτουργίες (συμπεριφορά) επιμύων, κατόπιν καταστροφής του βασικού πυρήνα του Meynert. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/19309

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Μέλλιος, Γεώργιος. “Η επίδραση της ριβαστιγμίνης σε ανώτερες φλοιϊκές λειτουργίες (συμπεριφορά) επιμύων, κατόπιν καταστροφής του βασικού πυρήνα του Meynert.” 2006. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed July 10, 2020. http://hdl.handle.net/10442/hedi/19309.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Μέλλιος, Γεώργιος. “Η επίδραση της ριβαστιγμίνης σε ανώτερες φλοιϊκές λειτουργίες (συμπεριφορά) επιμύων, κατόπιν καταστροφής του βασικού πυρήνα του Meynert.” 2006. Web. 10 Jul 2020.

Vancouver:

Μέλλιος . Η επίδραση της ριβαστιγμίνης σε ανώτερες φλοιϊκές λειτουργίες (συμπεριφορά) επιμύων, κατόπιν καταστροφής του βασικού πυρήνα του Meynert. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2006. [cited 2020 Jul 10]. Available from: http://hdl.handle.net/10442/hedi/19309.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Μέλλιος . Η επίδραση της ριβαστιγμίνης σε ανώτερες φλοιϊκές λειτουργίες (συμπεριφορά) επιμύων, κατόπιν καταστροφής του βασικού πυρήνα του Meynert. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2006. Available from: http://hdl.handle.net/10442/hedi/19309

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

14. Choi, Hyun Duck. Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 To date, there are only symptomatic treatments approved by the FDA and in wide clinical usage: Rivastigmine, Galantamine, Donepezil, and Memantine. However, their actual clinical… (more)

Subjects/Keywords: Alzheimer; Dementia; Efficacy; Safety; Tolerability; Comparison; AchEI; NMDA antagonist; Acetylcholinesterase inhibitor; Pharmacological; Clinical; treatment; Review; Memantine; Donepezil; Rivastigmine; Galantamine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Choi, H. D. (n.d.). Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/242811

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Choi, Hyun Duck. “Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia .” Thesis, University of Debrecen. Accessed July 10, 2020. http://hdl.handle.net/2437/242811.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Choi, Hyun Duck. “Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia .” Web. 10 Jul 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Choi HD. Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia . [Internet] [Thesis]. University of Debrecen; [cited 2020 Jul 10]. Available from: http://hdl.handle.net/2437/242811.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Choi HD. Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/242811

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

15. O'Regan, Jordana. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting.

Degree: 2014, University of Toronto

Cholinesterase inhibitors (ChEIs) are the first line pharmacotherapy for the symptoms of Alzheimer’s disease (AD). Though ChEIs offer modest cognitive benefits in early AD, literature… (more)

Subjects/Keywords: Alzheimer's Disease; cholinesterase inhibitors; discontinuation; cessation; donepezil; rivastigmine; galantamine; ChEIs; 0419

…56 Figure V: Administration procedure for rivastigmine 57 Figure VI: Study drug… …PRN – pro re nata (“as needed”) RCT – randomized control trial RIV – rivastigmine… …Problem Cholinesterase inhibitors (ChEIs) donepezil, galantamine and rivastigmine are… …donepezil and, more recently, the rivastigmine patch receiving approval for use in severe AD… …galantamine and rivastigmine are used more routinely in clinical practice. The pharmacological… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'Regan, J. (2014). Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/44051

Chicago Manual of Style (16th Edition):

O'Regan, Jordana. “Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting.” 2014. Masters Thesis, University of Toronto. Accessed July 10, 2020. http://hdl.handle.net/1807/44051.

MLA Handbook (7th Edition):

O'Regan, Jordana. “Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting.” 2014. Web. 10 Jul 2020.

Vancouver:

O'Regan J. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting. [Internet] [Masters thesis]. University of Toronto; 2014. [cited 2020 Jul 10]. Available from: http://hdl.handle.net/1807/44051.

Council of Science Editors:

O'Regan J. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting. [Masters Thesis]. University of Toronto; 2014. Available from: http://hdl.handle.net/1807/44051

16. Sarwary, Mariam. Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine.

Degree: Pharmacology, 2017, Umeå University

Subjects/Keywords: Alzheimer´s disease; Donepezil; Rivastigmine; Galantamine; Memantine and randomized controlled trails; Pharmaceutical Sciences; Farmaceutiska vetenskaper

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sarwary, M. (2017). Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine. (Thesis). Umeå University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sarwary, Mariam. “Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine.” 2017. Thesis, Umeå University. Accessed July 10, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sarwary, Mariam. “Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine.” 2017. Web. 10 Jul 2020.

Vancouver:

Sarwary M. Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine. [Internet] [Thesis]. Umeå University; 2017. [cited 2020 Jul 10]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sarwary M. Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine. [Thesis]. Umeå University; 2017. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Muriithi, Paul Mutuanyingi. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory.

Degree: 2014, University of Manchester

 The desire to enhance and make ourselves better is not a new one and it has continued to intrigue throughout the ages. Individuals have continued… (more)

Subjects/Keywords: adderall; ampakines; amphetamine; appeal to empathy; aricept; Aristotle; Baddeley; benzodiazepines; bioethics; Bostrom; brain stimulation; brain-computer interface; brain-machine interface; Brunet; Buchanan; caffeine; Cahil; Caplan; case; coercion; computers; confidentiality; consent; consequentialist; consistency; consolidation; conventional; criminal; damages; d-amphetamine; declarative memory; deep brain stimulation; Degrazia; deontological; diazepam; discrimination; donepezil; Douglas; drug mongering; duty; duty to remember; Dworkin; electroconvulsive therapy; Elliott; emotional distress; emotions; encoding; enhancement; enhancing technologies; epistemic knowledge; equality; ethical; evidence; exelon; explicit memory; eyewitness; eyewitness evidence; eyewitness testimony; Facebook; Farah; forget; Fukuyama; galantamine; gatekeepers; Ghetti; ginkgo biloba; Glover; glucocorticoids; glucose; greater good; Habermas; Harris; health; human dignity; human diversity; human enhancement; human nature; human rights; Hunter; identity; implicit memory; inauthentic; individual autonomy; inevitable; informed consent; internet; Jackson; justice; Kamm; Kass; Kolber; laissez faire; learning; legal; legal approach; lifelogging; living authentically; Loftus; long-term memory; Lynch; malleability of memory; mastery; McKibben; medicalization; meditation; Mehlman; Meilaender; memantine; Memory; memory dampening; memory enhancement; memory manipulation; memory processes; memory retention; memory retrieval; memory storage; methylphenidate; midazalom; misidentification of witnesses; mistaken identifications; mitigation; mnemonics; modafinil; moratorium; music; negative emotions; negligence; nondeclarative memory; non-pharmacological memory enhancement; nutrition; obligation; obstruction of justice; omega-3; optimum memory; Parens; person identity; personality; perverting justice; pharmacological means; philosophical approach; photographic; physical exercise; Pitman; policy; poly unsaturated fatty acids; precautionary approach; precautionary principle; preserving memories; President’s Council; primary memory; privacy; procedural memory; propofol; propranolol; provigil; razadyne; recall; recording audio; reference memory; regulation; regulatory authorities; regulatory bodies; relational memory; remembering; remembering fitly; remembering truly; risks; ritalin; rites; rituals; rivastigmine; safety; Sahakian; Sandberg; Sandel; Savulescu; Schacter; secondary memory; short-term memory; sleep; slippery slope; social; societies' interests; species-typical; society interests; species-typical functioning; Squire; Stanton; Strange; technological means; testimony; therapeutic; therapy; therapy-enhancement distinction; traditional; transcrannial direct current stimulation; transcrannial magnetic stimulation; traumatic memories; Tulving; ultimate prize; unnatural; unnatural means; Vaiva; video devices; virtual social networking; virtue ethics; Wagenaar; well-being; Wells; working memory; wrongful; wrongful acquittals; wrongful convictions; yoga; Kahane; Giordano; Bennett; Holm; Mental Capacity Act

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muriithi, P. M. (2014). A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498

Chicago Manual of Style (16th Edition):

Muriithi, Paul Mutuanyingi. “A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory.” 2014. Doctoral Dissertation, University of Manchester. Accessed July 10, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498.

MLA Handbook (7th Edition):

Muriithi, Paul Mutuanyingi. “A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory.” 2014. Web. 10 Jul 2020.

Vancouver:

Muriithi PM. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Jul 10]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498.

Council of Science Editors:

Muriithi PM. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory. [Doctoral Dissertation]. University of Manchester; 2014. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498

18. Muriithi, Paul Mutuanyingi. A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory.

Degree: PhD, 2014, University of Manchester

 The desire to enhance and make ourselves better is not a new one and it has continued to intrigue throughout the ages. Individuals have continued… (more)

Subjects/Keywords: 174; adderall; ampakines; amphetamine; appeal to empathy; aricept; Aristotle; Baddeley; benzodiazepines; bioethics; Bostrom; brain stimulation; brain-computer interface; brain-machine interface; Brunet; Buchanan; caffeine; Cahil; Caplan; case; coercion; computers; confidentiality; consent; consequentialist; consistency; consolidation; conventional; criminal; damages; d-amphetamine; declarative memory; deep brain stimulation; Degrazia; deontological; diazepam; discrimination; donepezil; Douglas; drug mongering; duty; duty to remember; Dworkin; electroconvulsive therapy; Elliott; emotional distress; emotions; encoding; enhancement; enhancing technologies; epistemic knowledge; equality; ethical; evidence; exelon; explicit memory; eyewitness; eyewitness evidence; eyewitness testimony; Facebook; Farah; forget; Fukuyama; galantamine; gatekeepers; Ghetti; ginkgo biloba; Glover; glucocorticoids; glucose; greater good; Habermas; Harris; health; human dignity; human diversity; human enhancement; human nature; human rights; Hunter; identity; implicit memory; inauthentic; individual autonomy; inevitable; informed consent; internet; Jackson; justice; Kamm; Kass; Kolber; laissez faire; learning; legal; legal approach; lifelogging; living authentically; Loftus; long-term memory; Lynch; malleability of memory; mastery; McKibben; medicalization; meditation; Mehlman; Meilaender; memantine; Memory; memory dampening; memory enhancement; memory manipulation; memory processes; memory retention; memory retrieval; memory storage; methylphenidate; midazalom; misidentification of witnesses; mistaken identifications; mitigation; mnemonics; modafinil; moratorium; music; negative emotions; negligence; nondeclarative memory; non-pharmacological memory enhancement; nutrition; obligation; obstruction of justice; omega-3; optimum memory; Parens; person identity; personality; perverting justice; pharmacological means; philosophical approach; photographic; physical exercise; Pitman; policy; poly unsaturated fatty acids; precautionary approach; precautionary principle; preserving memories; President’s Council; primary memory; privacy; procedural memory; propofol; propranolol; provigil; razadyne; recall; recording audio; reference memory; regulation; regulatory authorities; regulatory bodies; relational memory; remembering; remembering fitly; remembering truly; risks; ritalin; rites; rituals; rivastigmine; safety; Sahakian; Sandberg; Sandel; Savulescu; Schacter; secondary memory; short-term memory; sleep; slippery slope; social; societies' interests; species-typical; society interests; species-typical functioning; Squire; Stanton; Strange; technological means; testimony; therapeutic; therapy; therapy-enhancement distinction; traditional; transcrannial direct current stimulation; transcrannial magnetic stimulation; traumatic memories; Tulving; ultimate prize; unnatural; unnatural means; Vaiva; video devices; virtual social networking; virtue ethics; Wagenaar; well-being; Wells; working memory; wrongful; wrongful acquittals; wrongful convictions; yoga; Kahane; Giordano; Bennett; Holm; Mental Capacity Act

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muriithi, P. M. (2014). A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223

Chicago Manual of Style (16th Edition):

Muriithi, Paul Mutuanyingi. “A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory.” 2014. Doctoral Dissertation, University of Manchester. Accessed July 10, 2020. https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223.

MLA Handbook (7th Edition):

Muriithi, Paul Mutuanyingi. “A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory.” 2014. Web. 10 Jul 2020.

Vancouver:

Muriithi PM. A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Jul 10]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223.

Council of Science Editors:

Muriithi PM. A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory. [Doctoral Dissertation]. University of Manchester; 2014. Available from: https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223

.